Belgium· BE-AMP-SAM169145-00
Glucagen 1 mg
A glucagon product containing glucagon hydrochloride, recombinant, registered in Belgium by Novo Nordisk Pharma. The same ATC class is registered in 17 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Glucagon is registered in 17 of 19 countries.
Countries holding a registration under ATC H04AA01 (glucagon), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Glucagon · ATC H04AA01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of glucagon costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Glucagon · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$104.78
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Glucagon Hydrochloride, Recombinant
- Manufacturer
- Novo Nordisk Pharma
- Country
- Belgium (BE)
- ATC code
- H04AA01
- ATC class
- Glucagon
- Defined daily dose
- 3 mg, N
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1273994
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for glucagon.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucagon · interactions on record
22 records
- 1 moderate
- 21 minor
Most severe, free to view
- IndometacinM01AB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucagon in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/23769236-9349-4495-a80b-6de25f6257f6 GET /v1/drugs/23769236-9349-4495-a80b-6de25f6257f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Glucagen 1 mg",
"name_fr": "Glucagen 1 mg",
"name_nl": "Glucagen 1 mg",
"amp_code": "SAM169145-00",
"strengths": [
"1.0000",
"107.0000"
],
"pack_count": 2,
"substances": [
"Glucagon Hydrochloride, Recombinant",
"Glucagon",
"Lactose Monohydrate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Glucagon",
"authorisation_numbers": [
"BE169145"
]
}See everything about glucagon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.